|Synonyms||LY-135252, LY-139602, LY-139603, tomoxetine|
Atomoxetine is a substituted phenylpropylamine making it chemically related to fluoxetine, that serves as a selective noradrenaline reuptake inhibitor, with minimal (but not zero) affinity towards the serotonin transporter. It is primarily used in the treatment of attention-deficit/hyperactivity disorder (ADHD). In ADHD it is considered a first-line treatment, although the evidence suggests that it is less effective in this indication than stimulants.
- NCBI Bookshelf provides free book resources on this topic.
- PubMed provides review articles from the past five years (limit to free review articles or to systematic reviews)
- The TRIP database provides clinical publications about evidence-based medicine.
- ↑ Royal Australasian College of Physicians (2009). "Australian Guidelines on Attention Deficit Hyperactivity Disorder (ADHD)" (PDF). National Health and Medical Research Council. Royal Australasian College of Physicians. Retrieved 17 September 2014.